Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse off.

Sanne Jespersen, Bo Langhoff Hønge, Joakim Esbjörnsson, Candida Medina, David da Silva Té, Faustino Gomes Correira, Alex Lund Laursen, Lars Østergaard, Andreas Andersen, Peter Aaby, Christian Erikstrup, Christian Wejse

Journal: Tropical medicine & international health : TM & IH 2016;21(2):253-62

PMID: 26616349

Abstract

OBJECTIVES

Several studies have reported conflicting effects of sex on HIV-1 infection. We describe differences in baseline characteristics and assess the impact of sex on HIV progression among patients at a clinic with many HIV-2 and HIV-1/2 dually infected patients.

METHODS

This study utilised a retrospective cohort of treatment-naïve adults at the largest HIV clinic in Guinea-Bissau from 6 June 2005 to 1 December 2013. Baseline characteristics were assessed and the patients followed until death, transfer, loss to follow-up, or 1 June 2014. We estimated the time from the first clinic visit until initiation of ART, death or loss to follow-up using Cox proportional hazard models.

RESULTS

A total of 5694 patients were included in the study, 3702 women (65%) and 1992 men (35%). Women were more likely than men to be infected with HIV-2 (19% vs. 15%, P < 0.01) or dually infected with HIV-1/2 (11% vs. 9%, P = 0.02). For all HIV types, women were younger (median 35 vs. 40 years), less likely to have schooling (55% vs. 77%) or to be married (46% vs. 67%), and had higher baseline CD4 cell counts (median 214 vs. 178 cells/μl). Men had a higher age-adjusted mortality rate (hazard rate ratio (HRR) 1.29, 95% confidence interval (CI) 1.09-1.52) and were more often lost to follow-up (HRR 1.27, 95% CI 1.17-1.39).

CONCLUSION

Significant differences exist between HIV-infected men and women regardless of HIV type. Men seek treatment at a later stage and, despite better socio-economic status, have higher mortality and loss to follow-up than women.

© 2015 John Wiley & Sons Ltd.

Address: Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Experimental Medical Science, Section of Molecular Virology, Lund University, Lund, Sweden.; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; National HIV Programme, Ministry of Health, Bissau, Guinea-Bissau.; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.; Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.; Research Center for Vitamins and Vaccines (CVIVA), Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark.; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; GloHAU, Center for Global Health, School of Public Health, Aarhus University, Aarhus, Denmark.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.